Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit

Hims & Hers Health (NYSE:HIMS), a direct-to-consumer telehealth platform, closed Monday at $19.33, down 16.03%. The stock dropped as news of a lawsuit from Novo Nordisk (NYSE:NVO) came on top of Friday’s regulatory crackdown on non-FDA-approved compounds. Trading volume reached 143.5 million shares, coming in about 688% above its three-month average of 18.2 million shares. Hims & Hers IPO'd in 2019 and has grown 97% since going public.The S&P 500 (SNPINDEX:^GSPC) added 0.47% to finish Monday at 6,965, while the Nasdaq Composite (NASDAQINDEX:^IXIC) gained 0.90% to close at 23,239. Among telehealth and online pharmacy peers, Teladoc Health (NYSE:TDOC) closed at $4.98, down 0.60%, and American Well (NYSE:AMWL) finished at $4.29, slipping 3.38% as investors weighed regulatory risks.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool